Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Advances in Photoelectric Therapy for the Early Intervention and Treatment of Traumatic Scars

Authors Tian Q, Zhang YX, Wang JJ, Huang GB 

Received 5 February 2023

Accepted for publication 28 March 2023

Published 4 April 2023 Volume 2023:16 Pages 869—877

DOI https://doi.org/10.2147/CCID.S407361

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Anne-Claire Fougerousse



Qi Tian,1,2,* Yi-Xin Zhang,3,* Jin-Jing Wang,4,* Guo-Bao Huang2

1Department of Clinical Medicine, Weifang Medical University, Weifang, People’s Republic of China; 2Department of Burns and Reconstructive Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, People’s Republic of China; 3Centre for Translational Medicine, Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China; 4Department of Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Guo-Bao Huang, Department of Burns and Reconstructive Surgery, Central Hospital Affiliated to Shandong First Medical University, No. 105, Jiefang Road, Lixia District, Jinan, Shandong Province, 250013, People’s Republic of China, Tel +86 531-55865707, Email [email protected]

Abstract: Traumatic scar is a disease that affected approximately tens of millions of patients worldwide. According to the histological and morphological properties of scars, the traumatic scar typically includes superficial scar, atrophic scar, hypertrophic scar, and keloid. Its formation is a natural consequence of wound healing, regardless of whether the wound was caused by trauma or surgery. However, the production of scars has considerable impacts on the physical and mental health of patients, even causing substantial aesthetic and functional impairments. Prevention or early treatment of scars is the most suitable therapeutic method, including surgical and non-surgical procedures; nevertheless, the benefits of non-operative therapies for scars are quite limited, and surgical treatments are always hard to achieve satisfying outcomes. Through the application of innovative technologies such as lasers, intense pulsed light, and radiofrequency, significant progress has been made in the treatment of traumatic scars. This review highlights the current advancements of photoelectric therapy for the prevention and treatment of various traumatic scars, which may throw light on innovative therapeutic options for scar therapies.

Keywords: scars, photoelectric therapy, lasers, intense pulsed light, radiofrequency

Introduction

Traumatic scars are inevitable consequences of healing in skin and soft tissue after various injuries, including rubbing or scraping, sharp objects piercing the skin, and thermal or chemical burns.1 It affected approximately tens of millions of patients worldwide, with common morbidities such as itching, pain, contracture-related facial malformations, and even reduced range of motion in the functioning joints.2,3 These physiological problems always bring low self-esteem, depression and anxiety disorders, and posttraumatic stress disorder to these patients, especially in the world of the increasing demands of beauty.4 Thus, early intervention and treatment of scars are imperative to shorten the immature period of scars and effectively control the development of scars, thereby decreasing the incidence of morbidities and psychological problems.

The surgical and non-surgical approaches are the current treatment options for the treatment and management of scars.5 In detail, surgery is always used to address inadequacies and abnormalities and is particularly useful in patients with functional impairment caused by scar contracture. Nevertheless, the high recurrence rate (more than 40%) has compelled the implementation of adjuvant chemotherapy after surgery.6 The non-surgical techniques mainly include photoelectric therapy, radiation therapy, silicone products, intralesional injection of steroids or other medicines, compression garments, etc. However, many of these therapies in clinical practice remain suboptimal. For example, it is believed that silicone products can effectively limit the hyperplasia of scars, improve pliability, and reduce scarring incidence,7 but inconsistent findings from recent research have made it difficult to draw a firm judgment about whether the data supports the use of silicone treatment.8,9 Moreover, patients with scars can be benefited from local injections of glucocorticoids to reduce the area of scars and uncomfortable symptoms, but it may be related to many inadequately studied systemic effects, such as osteoporosis, Cushingoid syndrome, and immunosuppression.10 These limitations make the development of novel treatment options and majorization of the current treatment protocols urgent.

In recent years, clinicians have witnessed advances in the aesthetics and functionality of treating traumatic scars with photoelectric therapy, offering convenience for medical staff and benefits including little invasion, quick healing, and reduced risk of scar treatment for patients. This review will summarize the advances in photoelectric therapy for the early intervention and treatment of different traumatic scars. Hopefully, this review can serve as a guide for therapeutic applications as well as future clinical and basic research.

Classification and Evaluation of Traumatic Scars

According to the histological and morphological characteristics, scars can be typically categorized as superficial scar, atrophic scar, hypertrophic scar, and keloid.11 Injuries (eg, trauma, surgery, etc.) and chronic inflammation (eg, acne, etc.) that damage dermal collagen and/or subcutaneous tissue are the main causes of the first two, also known as non-hypertrophic scars.12 They can come into touch with deep muscles and tendons, and can be either firm or soft, flat or just slightly higher or lower than the surrounding skin surface.13 Moreover, the reticular dermis layer, which displays excessive angiogenesis, ongoing inflammation, and significant collagen buildup, is where hypertrophic scars and keloids originate.14 Traditional hypertrophic scars only have nodules, whereas classic keloids spread aggressively, rarely go away on their own, and contain keloidal collagen at the histologic level.15 Studies have suggested that keloids and traditional hypertrophic scars are two extreme manifestations of the same skin disorder because many scars exhibit the pathologic and clinical characteristics of both of them.16

These different types of scars should be comprehensively evaluated before photoelectric therapy, including medical history, family history, local symptoms and signs of scar (color and texture) etc.17 In order to facilitate the clinical application of photoelectric technology in the treatment of scars, it is recommended that patients with traumatic scars should be evaluated based on the scar color (red or not red), location (limbs, face, or other lesions), type (hypertrophic, non-hyperplastic), and patient characteristics (eg, skin type, psychological expectations) to guide clinicians to choose the appropriate treatment plan, photoelectric equipment, and monitor the treatment effects.18

Laser

Pulsed Dye Laser

Pulsed Dye Laser (PDL, wavelength 585/595 nm) works by selectively photolyzing scar tissue in order to break down microvessels in scars and prevent their growth.19 As red is the PDL’s target chromophore, the laser’s light energy is directed at the chromophore in oxyhemoglobin, where it is absorbed and transformed into heat energy, resulting in coagulation necrosis.20 PDL is typically used in early hyperemic scars to limit early scar development and lessen erythema since it can disrupt the microvascular structure.21 Deng et al demonstrated that PDL (585 nm) effectively decreased the thickness of immature hypertrophic scar, scar erythema, and blood perfusion in 45 patients with immature hypertrophic scar.22 Ouyang et al found that patients’ new trauma scars seem to be benefited clinically from the use of 595 nm tunable PDL.23 Furthermore, Kim et al showed that when eight treatment sessions with the 595 nm PDL (with the dosage gradually raised by 0.5 J/cm2) were administered to 19 patients with hypertrophic scars following thyroid surgery at intervals of 4 to 6 weeks, significant improvements were observed in the mean height, pigmentation, and vascularity ratings.24 A randomized, controlled trial also found in 40 individuals (41 scars) who had undergone postoperative knee arthroplasties, the areas that had been laser-treated obtained considerably higher scores across the board for the Vancouver scar scale (VSS), suggesting the 595 nm PDL was a reliable and secure therapeutic alternative for the treatment of surgical scars left over from a knee arthroplasty.25 A meta-analysis also suggested that PDL may be a secure and efficient way to repair surgical scars, because PDL substantially reduced the VSS scores in height, vascularity, pliability, and pigmentation, with no overtly harmful impacts on the majority of persons.26 To treat hypertrophic burn scars in Chinese children with Fitzpatrick skin types III and IV, a retrospective research was conducted to determine the best PDL therapy settings and indicated that early intervention, sensible treatment intervals, and modest PDL fluence were ideal.27

Diode Laser

Diode laser can dramatically speed up wound healing by activating tissue regeneration, reducing scarring, and inducing the expression of heat shock proteins (HSP70) in the epidermis and dermis around the lesion by thermal impacts.28 In a prospective cohort study by Li et al, 21 patients with hypertrophic scars or keloids were treated with 1 to 3 sessions of the intralesional 1470 nm bare-fiber diode laser. The results showed that the hypertrophic and keloid scars significantly improved with no side effects, including skin infection, hypo/hyperpigmentation, or recurrence.29 In a research by Mohsen et al, it was discovered that using a diode laser with a wavelength of 806 nm and a power of 100 mw greatly improved the pigmentation, height, pliability, and vascularity of the scars on 80 patients who had cleft lip scars.30 Another study for a total of 19 patients who have a history of inflamed keloids with episodes of infection or abscess demonstrated that 1470 nm fiber laser treatment could improve inflamed keloids fairly well by decreasing inflammation, and relative stabilization of collagen composition. Therefore, it is an effective minimally invasive scar therapy.31 Casanova found that after bilateral breast reduction surgery, a portable 1210 nm diode laser was employed in 40 female patients. It was applied to one breast right away after surgery, while the other breast served as the control for the experiment. The findings demonstrated that diode laser can improve the scars’ volume, look, and roughness, with no negative side effects.32

Ablative Fractional Laser

Ablative fractional laser (AFL) mainly includes fractional CO2 laser (wavelength: 10,600 nm) and erbium:yttrium-aluminium-garnet (Er:YAG) laser (wavelength: 2940 nm). Current studies found that AFL is not only just used to treat mature scars: during the first stages of the wound and burn healing, AFL may not only drastically lessen the scar formation but also reduce scar thickness and improve the appearance and function.33 A meta-analysis of 25 studies also concluded that fractional CO2 laser treatment considerably reduced the signs and symptoms of burn scars as determined by both objective and subjective tools.34 Another meta-analysis that included 8 research found that although treatment protocols differed across them, fractional CO2 ablative laser therapy resulted in an average VSS improvement of 29% among 282 patients.35 On both patient- and observer-rated measurements, Patel et al convincingly demonstrated that CO2-AFL treatment reduces hypertrophic burn scars of pediatric patients, demonstrating that CO2-AFL may repair hypertrophic burn scars in children and offering a less intrusive, more effective alternative to invasive therapies as well as a more quick and immediate option than more traditional scar treatments.36 Moreover, patients with hypertrophic scars who had CO2-AFL treatment reported considerably better sleep quality and less discomfort and itchiness.37 Furthermore, Radmanesh et al found PDL and fractional CO2 laser were similarly effective.38 Elgarhy et al also found in 30 patients with old hypertrophic scars, both PDL and the ablative fractional CO2 laser were successful in treating old hypertrophic scars; however, the latter approach was more effective in reducing the pliability and height of scars.39

In terms of Er:YAG laser, thermal burn scars may be effectively treated using it, which can also improve both the patient’s and the doctor’s perceptions of the condition.40 A randomized controlled study revealed that fractional Er:YAG laser (2940 nm) and micro-needling are equally safe and effective for post-traumatic atrophic scars, but the latter approach requires more frequent sessions to provide satisfactory results that are comparable to those of fractional lasers.41 In the patients with scars caused by self-inflicted injury using razor blades, Er:YAG was a secure and efficient option for them, but they needed multiple treatments and increasing joules in every session.42

Non-Ablative Fractional Laser

Unlike AFL, non-ablative fractional laser (NAFL) can target just the dermal tissue under the skin’s surface, heating it by infrared radiation without harming the epidermis. It is often used in combination with other treatments when treating scars. In terms of the treatment of hypertrophic scars and keloids, Shin et al found the combination therapy using a NAFL and intralesional steroid injection had superior outcomes with fewer treatment sessions, higher patient satisfaction, and longer remission times.44 A prospective, randomized, blinded pilot study also demonstrated that such a combination treatment decreased the discomfort, itchiness, pliability, thickness, and alleviation of scars.45 Guo et al suggested that the combination of a low dosage local application of compound betamethasone with a 1565 nm NAFL can significantly enhance the immature red hypertrophic scars with no negative side effects, giving practitioners a new tool to combat difficult-to-treat early scar forms.46 Moreover, the efficient production of post-epicanthoplasty scars can be enhanced by early NAFL therapy in conjunction with silicones.47 Besides, Taheri et al discovered that NAFL (1540 nm) is a viable and secure treatment option for atrophic cutaneous leishmaniasis scars which is one of the endemic illnesses in Iran, especially in those with darker skin.48

Intense Pulsed Light

Intense pulsed light (IPL) can penetrate the skin and be selectively absorbed by hemoglobin. Then, it inhibits scar hyperplasia by denaturing and coagulating hemoglobin, damaging the vascular endothelial cells in the scar, and occluding the blood vessels.49 A study that included 28 patients with hypertrophic scars who either had cryotherapy or IPL, showed that cryotherapy is more successful than IPL in treating hypertrophic scars on both a clinical and histological level, however, it comes with additional risks.50 In a research conducted in Turkey, patients with hypertrophic scars and keloids were treated with an average of eight IPL, and more than 90% of patients showed substantial improvement in the height, erythema, and hardness of their scars.51 Another study found in 37 patients with burn scars, the narrow-spectrum IPL can improve 93.75% of scars.52

Micro-Plasma Radio-Frequency Technology

Micro-plasma radio-frequency (RF) is an approach that micro-exfoliates the epidermis to promote rapid epithelialization and produces a thermal effect on the dermis, thereby stimulating the fibroblast regeneration.53 Compared with other photoelectric therapies, Micro-plasma RF has exact curative effects, fewer adverse reactions, and shorter recovery time, and has been widely used in the treatment of early scars and mature scars.54 Zhang et al used 6 New Zealand white rabbits to generate a total of seventy-two hypertrophic scar models in the rabbits’ ears, then randomly separated them into experimental and control groups. A month following the successful construction of the model, the experimental group was treated with micro-plasma RF. After 30 days of therapy, the number of scar micro-vessels, interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1) dropped considerably in comparison to the control group, and the micro-vessel density was positively linked with the expression of IL-8 and MCP-1 in both groups.55

Combination Therapy

Combination treatments are commonly used in the treatment of scars. Song et al assessed the efficacy of early combined AFL and PDL therapy after scar revision. In the group of 14 patients who had scar correction and a total of 4 treatments using a 10,600-nm AFL and a 595-nm PDL, starting 2 weeks after scar revision and continuing every 4 weeks thereafter, all VSS scores dramatically improved with the exception of scar height. Besides, during follow-up, these patients experienced no negative side effects (wound disruption, hyper- or hypopigmentation). It suggested that early combined CO2 AFL and PDL therapy successfully and safely reduced scar formation.56 Matuszczak et al demonstrated unequivocally that PDL combined fractional CO2 laser for burn scars can enhance their texture, color, and function. A prospective, randomized control trial found in comparison to control and CO2 laser alone, treatment with a combination of IPL and fractional CO2 laser showed greater average improvements in both texture and color across the majority of examined scar domains, indicating by employing a variety of wavelengths to target the different chromophores in scars, a multi-photo-thermolytic approach combining IPL with CO2 AFL could be successful in treating hypertrophic scars.57 However, Laura et al looked at hypertrophic burn scars of different ages, origins, and thicknesses. Although greater early decrease is seen in thicker scars when utilizing CO2, PDL, or both laser modalities, there was no clinically significant advantage discovered comparing combined therapy to individual therapy.58 Nevertheless, when inhibiting the early hypertrophic scar in rabbit ears, fractional CO2 laser therapy has been demonstrated to be more effective than either pulsed dye laser treatment or CO2 laser treatment alone.59 Additionally, despite the use of a high-energy dosage of fractional CO2 laser and an average of five sessions of treatment, patients with acne scars dramatically improved ECCA scores, minor pain experience, and low rates of side effects with the use of fractional CO2 laser and fractional microneedle radiofrequency. Another study also performs a clinical trial on twenty patients with atrophic facial acne scars who were randomly split into two groups and given three monthly treatments each using an AFL with low energy plus a NAFL on one side of their faces and high and low energy lasers on the other. This study found that whilst utilizing an AFL with high intensity resulted in an improvement in patients’ acne scars, it is noteworthy that the most optimal outcomes were achieved through the amalgamation of AFL and NAFL.60 Furthermore, a randomized clinical trial with 30 patients who had keloids and hypertrophic scars found that treating keloids and hypertrophic scars with long-pulsed Nd:YAG laser is both efficient and safe. While keloids respond similarly to both fractional CO2 and Nd:YAG laser treatment, hypertrophic scars respond better to fractional CO2 laser treatment. Combination in the same session did not significantly increase the benefits, and its adverse effects were larger.43

Not only that, compared to single treatment of Er:YAG or no therapy, the combination of IPL and Er:YAG has shown more beneficial benefits on scar avoidance. In the early stages of wound healing, IPL/Er:YAG treatment may be a reliable and secure method for preventing the formation of scars.61 Besides, both the combination of IPL and RF and the 1064-nm Nd:YAG laser were effective in treating hypertrophic scars, but only the combined method showed a substantial improvement in the clinical and histological findings.62 Furthermore, Li et al found that fractional micro-plasma RF coupled with fractional ablative CO2 laser is more successful than single therapy for the treatment of hypertrophic scars. Additionally, repeated therapies may increase the efficacy of combination therapy, and patients should be urged to seek treatment as soon as feasible.63 To find the best technique for treating pathological scars, a network meta-analysis compared and ranked the effectiveness of laser and IPL treatments. It was shown that the combination of IPL and CO2 laser has the greatest likelihood of being the most successful intervention.64

Molecular Changes Induced by Photoelectric Therapy for Scars

Skin wound healing involves three phases: inflammation, proliferation, and regeneration. Abnormalities in these phases can result in various scarring. In terms of hypertrophic scar and keloid, inflammatory cells infiltrate the damaged area and release cytokines after injury, stimulating the migration and proliferation of keratinocytes and fibroblasts.65 Fibroblasts secrete extracellular matrix (ECM) proteins (ie Collagen, fibronectin, hyaluronic acid, etc.), forming granulation tissue.66 Increased vascularization and angiogenesis occur during the proliferation phase, which is heightened in hypertrophic scars.67 Myofibroblasts, activated by transforming growth factor-β1 (TGF-β1), contract the wound and reduce its size.68 Re-epithelization begins with keratinocyte proliferation and a decrease in blood vessels, leading to fewer fibroblasts in mature scar tissue.69 In addition, studies have shown that atrophic scars’ lack of thick collagen fiber deposition in the dermis may be due to an imbalance between collagen synthesis and breakdown, which is mediated by matrix metalloproteinases (MMPs) and their inhibitors.70 Moreover, the degree and length of inflammation are also involved in the formation of atrophic scars, and the aberrant extracellular matrix metabolism may be impacted by exacerbated inflammation and aberrant epidermal proliferation caused by enhanced transforming growth factor 1 (TGF-1) signaling.71 While improvements in scar thickness, color, and pliability were noticed one month following laser therapy, MMP-2 and TIMP-1 plasma levels also decreased.70

A series of metabolic alterations will be brought on by the photoelectric treatment. Histological studies showed that the fractional laser could initiate the inflammatory process, and MMPs and heat shock proteins controlled collagen formation and remodelling.71 Ablative fractional CO2 laser therapy was observed to improve the architecture of the skin layers, decrease collagen type I, and raise collagen type III, as well as reduce the plasma levels of metalloproteinase 1 (TIMP-1) and MMP-2 one month following laser treatment.72 However, MMP-2 plasma levels could be increased soon after burn damage.73 Furthermore, 585-nm PDL affected the signalling pathway and caused a breakdown of collagen and fibroblast death.74 In this process, the metalloproteinases and IL-6 were activated hence the decrease of ECM, and transforming growth factor beta (TGF-β) and platelet-derived growth factor (PDGF) are blocked.74 Moreover, in a rabbit model, the use of a fractional CO2 laser with a 595-nm PDL can enhance the shape and histology of hypertrophic scars by reducing TGFβ1 and proliferating cell nuclear antigen (PCNA) protein expression.75 In addition, another study found that the mRNA expression of MMP1, 2, and 3 as well as chemokines (Chemokine (C-X-C motif) ligand 1, 2, 5, and 6) and interleukins (IL-6, IL-8, and IL-24) was considerably higher in tissue samples obtained three days following fractional Er:YAG laser treatment.76 In terms of the treatment of IPL, it suppressed levels of IL-6, tumor necrosis factor-alpha (TNF-α), MMPs, and proteolytic enzymes while raising levels of IL-10 and TGF-β in skin cells.50,77 Overall, the continuous investigations of novel indications, technologies, and methods to enhance efficacy and safety were promising, but a deeper comprehension of the underlying mechanisms was still needed.

Conclusions

Laser, IPL, and micro-plasma RF are effective and safe methods to improve the appearance of trauma scars, including erythema, texture, thickness, and pigmentation. These approaches can also alleviate unpleasant symptoms like pain and itching and improve the function of scar lesions, eliminating the need for surgical excision. It’s recommended to consider these methods immediately after scar formation following wound healing, typically within one week after suture removal, to minimize scar development. Various photoelectric therapy devices can be used alone or in combination to treat scars and most studies indicate that combining different photoelectric therapies or scar treatment methods at an early stage may be more effective. However, due to the distinct characteristics and limitations of each photoelectric technology, the optimal treatment of traumatic scars with these technologies has not been fully optimized, and there are still many unanswered questions regarding the long-term consequences and effectiveness of various procedures. In addition, scar formation is a complex process that can be influenced by a multitude of factors, so the same photoelectric treatment may have varying effects on scars with different characteristics. Thus, healthcare professionals should consider various factors that influence scar formation when treating the scars, such as the type of trauma, genetics, skin type, and predilection or location where the scar occurs. In the future, larger-scale prospective clinical trials and physiological studies will be required to investigate the optimal treatment options for traumatic scars and the biological mechanism in order to promote the clinical practice of these techniques in the treatment of traumatic scars and to better understand these techniques.

Funding

This work was supported by the Youth Science Fund Cultivation Funding Program of Shandong First Medical University [202201-130] and Rong-Xiang Regenerative Medicine Fund of Shandong University [2019SDRX-08].

Disclosure

The authors declare no conflicts of interest.

References

1. Jagdeo J, Shumaker PR. Traumatic scarring. JAMA Dermatol. 2017;153(3):364. doi:10.1001/jamadermatol.2016.5232

2. Farrukh O, Goutos I. Scar Symptoms: Pruritus and Pain. Springer; 2020.

3. Poetschke J, Gauglitz GG. Specific attention areas in scar management: specific scar management depending on anatomical features (Face, Hair, Breast, Hand, Joints, Foot). In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, editors. Textbook on Scar Management: State of the Art Management and Emerging Technologies. Springer; 2020.

4. Van Loey NEE. Psychological impact of living with scars following burn injury. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, editors. Textbook on Scar Management: State of the Art Management and Emerging Technologies. Springer; 2020.

5. Dastagir K, Obed D, Bucher F, Hofmann T, Koyro KI, Vogt PM. Non-invasive and surgical modalities for scar management: a clinical algorithm. J Pers Med. 2021;11:12. doi:10.3390/jpm11121259

6. Gold MH, Nestor MS, Berman B, Goldberg D. Assessing keloid recurrence following surgical excision and radiation. Burns Trauma. 2020;8:tkaa031. doi:10.1093/burnst/tkaa031

7. De Decker I, Hoeksema H, Verbelen J, et al. The use of fluid silicone gels in the prevention and treatment of hypertrophic scars: a systematic review and meta-analysis. Burns. 2022;48(3):491–509. doi:10.1016/j.burns.2022.03.004

8. De Decker I, Hoeksema H, Vanlerberghe E, et al. Occlusion and hydration of scars: moisturizers versus silicone gels. Burns. 2022. doi:10.1016/j.burns.2022.04.025

9. Tian F, Jiang Q, Chen J, Liu Z. Silicone gel sheeting for treating keloid scars. Cochrane Database Syst Rev. 2023;1(1):CD013878. doi:10.1002/14651858.CD013878.pub2

10. Stout A, Friedly J, Standaert CJ. Systemic absorption and side effects of locally injected glucocorticoids. PM R. 2019;11(4):409–419. doi:10.1002/pmrj.12042

11. Tripathi PB, Nelson JS, Wong BJ. Posttraumatic laser treatment of soft tissue injury. Facial Plast Surg Clin North Am. 2017;25(4):617–628. doi:10.1016/j.fsc.2017.06.012

12. DesJardins-Park HE, Gurtner GC, Wan DC, Longaker MT. From chronic wounds to scarring: the growing health care burden of under-and over-healing wounds. Adv Wound Care. 2022;11(9):496–510. doi:10.1089/wound.2021.0039

13. Maninder K, Richa R, Dinesh AP, Suman P. Factors affecting the outcome of fractional carbon dioxide laser resurfacing of various types of scars in skin of color. J Cosmet Dermatol. 2022;21(9):3842–3847. doi:10.1111/jocd.14698

14. Wang ZC, Zhao WY, Cao Y, et al. The roles of inflammation in keloid and hypertrophic scars. Front Immunol. 2020;11:603187. doi:10.3389/fimmu.2020.603187

15. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022;149(1):79e–94e. doi:10.1097/PRS.0000000000008667

16. Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 2020;8:360. doi:10.3389/fcell.2020.00360

17. Liu L, Wang H, Dong J. Classification of and the latest photoelectric therapy for epidermal nevi. Chin J Plastic Reconstr Surg. 2022;4(2):91–96. doi:10.1016/j.cjprs.2022.04.003

18. Anderson RR, Donelan MB, Hivnor C, et al. Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report. JAMA Dermatol. 2014;150(2):187–193. doi:10.1001/jamadermatol.2013.7761

19. Erceg A, de Jong EMJG, van de Kerkhof PCM, Seyger MMB. The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. J Am Acad Dermatol. 2013;69(4):609–615.e8. doi:10.1016/j.jaad.2013.03.029

20. Cao Y, Wang F, Jia Q, et al. One possible mechanism of pulsed dye laser treatment on infantile hemangioma: induction of endothelial apoptosis and serum vascular endothelial growth factor (VEGF) level changes. J Lasers Med Sci. 2014;5(2):75–81.

21. Hultman CS, Edkins RE, Lee CN, Calvert CT, Cairns BA. Shine on: review of laser- and light-based therapies for the treatment of burn scars. Dermatol Res Pract. 2012;2012:243651. doi:10.1155/2012/243651

22. Deng H, Tan T, Luo G, Tan J, Li-Tsang CWP. Vascularity and thickness changes in immature hypertrophic scars treated with a pulsed dye laser. Lasers Surg Med. 2020. doi:10.1002/lsm.23366

23. Ouyang H, Tan J, Li G, Lei Y. Clinical effect of 595 nm tunable pulsed pulsed dye laser treatment of fresh trauma scars. J Chin Physician. 2019;12:503–506.

24. Kim JC, Choi JW, Kim YC. A prospective study to evaluate the treatment effect of pulsed dye laser on thyroidectomy hypertrophic scars using 3D imaging analysis. Lasers Surg Med. 2022;54(8):1082–1088. doi:10.1002/lsm.23584

25. Pongcharoen P, Pongcharoen B, Disphanurat W. The effectiveness of a 595 nm pulsed-dye-laser in the treatment of surgical scars following a knee arthroplasty. J Cosmet Laser Ther. 2019;21(6):352–356. doi:10.1080/14764172.2019.1661488

26. Cai Y, Zeng X, Ying J, Zhu Y, Qiu Y, Xiang W. Efficacy and safety of pulsed dye laser for the treatment of surgical scars: a systematic review and meta-analysis. Lasers Med Sci. 2022;37(2):1273–1282. doi:10.1007/s10103-021-03385-z

27. Li N, Yang L, Cheng J, et al. A retrospective study to identify the optimal parameters for pulsed dye laser in the treatment of hypertrophic burn scars in Chinese children with Fitzpatrick skin types III and IV. Lasers Med Sci. 2021;36(8):1671–1679. doi:10.1007/s10103-021-03252-x

28. Dawood MS, Salman SD. Low level diode laser accelerates wound healing. Lasers Med Sci. 2013;28(3):941–945. doi:10.1007/s10103-012-1182-4

29. Li K, Nicoli F, Cui C, et al. Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique. Sci Rep. 2020;10(1):21694. doi:10.1038/s41598-020-78738-9

30. Abdul Mohsen M, El Husseiny Saafan AM, El-Basiouny MS, et al. Evaluating the effect of low power diode laser 806 nm on the healing of unilateral cleft lip scar: an open-label comparative study. Cleft Palate Craniofac J. 2023;60(1):21–26. doi:10.1177/10556656211053536

31. Li K, Nicoli F, Xi WJ, et al. The 1470 nm diode laser with an intralesional fiber device: a proposed solution for the treatment of inflamed and infected keloids. Burns Trauma. 2019;7:5. doi:10.1186/s41038-019-0143-6

32. Casanova D, Alliez A, Baptista C, Gonelli D, Lemdjadi Z, Bohbot S. A 1-year follow-up of post-operative scars after the use of a 1210-nm Laser-Assisted Skin Healing (LASH) technology: a randomized controlled trial. Aesthetic Plast Surg. 2017;41(4):938–948. doi:10.1007/s00266-017-0820-4

33. You HJ, Choi YS, Hwang NH, Kim DW, Oh KH, Kwon SY. The outcome of early ablative fractional laser treatment for thyroidectomy scars. Lasers Surg Med. 2020;52(8):721–729. doi:10.1002/lsm.23217

34. Peng W, Zhang X, Kong X, Shi K. The efficacy and safety of fractional CO2 laser therapy in the treatment of burn scars: a meta-analysis. Burns. 2021;47(7):1469–1477. doi:10.1016/j.burns.2021.08.010

35. Mahar PD, Spinks AB, Cleland H, et al. Improvement of burn scars treated with fractional ablative CO2 lasers—A systematic review and meta-analysis using the Vancouver scar scale. J Burn Care Res. 2020;42(2):200–206. doi:10.1093/jbcr/iraa130

36. Patel SP, Nguyen HV, Mannschreck D, Redett RJ, Puttgen KB, Stewart FD. Fractional CO2 laser treatment outcomes for pediatric hypertrophic burn scars. J Burn Care Res. 2019;40(4):386–391. doi:10.1093/jbcr/irz046

37. Lv K, Liu H, Xu H, et al. Ablative fractional CO2 laser surgery improving sleep quality, pain and pruritus in adult hypertrophic scar patients: a prospective cohort study. Burns Trauma. 2021;9:tkab023. doi:10.1093/burnst/tkab023

38. Radmanesh M, Mehramiri S, Radmanesh R. Fractional CO2 laser is as effective as pulsed dye laser for the treatment of hypertrophic scars. J Dermatolog Treat. 2021;32(6):576–579. doi:10.1080/09546634.2019.1687821

39. Elgarhy LH, El-Tatawy RA, Abdelaziz D, Dogheim NN. Pulsed dye laser versus ablative fractional CO2 laser in treatment of old hypertrophic scars: clinicopathological study. Wound Repair Regen. 2021;29(3):417–424. doi:10.1111/wrr.12904

40. Sipprell WH, Bell DE, Ibrahim SF. Fractionally ablative Er: YAG laser resurfacing for thermal burn scars: a split-scar, controlled, prospective cohort study. Dermatol Surg. 2020;46(12):1577–1582. doi:10.1097/DSS.0000000000002650

41. Agamia NF, Sorror O, Alrashidy M, Tawfik AA, Badawi A. Clinical and histopathological comparison of microneedling combined with platelets rich plasma versus fractional erbium-doped yttrium aluminum garnet (Er: YAG) laser 2940 nm in treatment of atrophic post traumatic scar: a randomized controlled study. J Dermatolog Treat. 2021;32(8):965–972. doi:10.1080/09546634.2020.1729334

42. Cenk H, Sarac G. Efficacy of 2940 nm multifractional Er: YAG lasers in self-inflicted razor blade incision scars. J Cosmet Dermatol. 2022;21(3):1013–1017. doi:10.1111/jocd.14678

43. Tawfic SO, El-Tawdy A, Shalaby S, et al. Evaluation of fractional CO2 versus long pulsed Nd:YAGLasers in treatment of hypertrophic scars and keloids: a randomized clinical trial. Lasers Surg Med. 2020;52(10):959–965. doi:10.1002/lsm.23249

44. Shin J, Cho JT, Park SI, Jung SN. Combination therapy using non-ablative fractional laser and intralesional triamcinolone injection for hypertrophic scars and keloids treatment. Int Wound J. 2019;16(6):1450–1456. doi:10.1111/iwj.13213

45. Cheon JH, Hwang YJ, Yoon ES, Jung KY, Park SH, Chung JH. Effectiveness of a combination therapy using non-ablative fractional laser and intralesional triamcinolone injection for thyroidectomy scar treatment: a prospective, randomized, blinded pilot study. J Cosmet Dermatol. 2022;21(7):2793–2800. doi:10.1111/jocd.14485

46. Guo Q, Xu P, Ye J. Observation on the efficacy of 1565-nm non-ablative fractional laser combined with compound betamethasone topical application on the treatment of early scar in Chinese patients. Lasers Med Sci. 2022;37(7):2947–2953. doi:10.1007/s10103-022-03564-6

47. Zhang B, Yang E, Zhang H. Efficacy of early application of 1540 nm non-ablative fractional laser and silicones to improve post-epicanthoplasty scars. Aesthetic Plast Surg. 2022;46(5):2452–2458. doi:10.1007/s00266-022-02866-y

48. Taheri AR, Mashayekhi-Goyonlo V, Salehi M, Mohammadzadeh H. Non-ablative fractional 1540-nm er: glass laser in the treatment of atrophic cutaneous leishmaniasis scars. Lasers Surg Med. 2020;52(2):182–187. doi:10.1002/lsm.23136

49. Babilas P, Schreml S, Szeimies RM, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42(2):93–104. doi:10.1002/lsm.20877

50. Salem SAM, Abdel Hameed SM, Mostafa AE. Intense pulsed light versus cryotherapy in the treatment of hypertrophic scars: a clinical and histopathological study. J Cosmet Dermatol. 2021;20(9):2775–2784. doi:10.1111/jocd.13971

51. Karmisholt KE, Wenande E, Thaysen-Petersen D, Philipsen PA, Paasch U, Haedersdal M. Early intervention with non-ablative fractional laser to improve cutaneous scarring-A randomized controlled trial on the impact of intervention time and fluence levels. Lasers Surg Med. 2018;50(1):28–36. doi:10.1002/lsm.22707

52. Shen W, Rui JIN, Jing MI, Juan W, Jiying D. Evaluation of narrow-spectrum intense pulsed light for the treatment of burn scar. J Tissue Eng. 2015;11(3):196.

53. Kinney BM, Andriessen A, DiBernardo BE, et al. Use of a controlled subdermal radio frequency thermistor for treating the aging neck: consensus recommendations. J Cosmet Laser Ther. 2017;19(8):444–450. doi:10.1080/14764172.2017.1343952

54. Tatlıparmak A, Aksoy B, Shishehgarkhaneh LR, Gökdemir G, Koç E. Use of combined fractional carbon dioxide laser and fractional microneedle radiofrequency for the treatment of acne scars: a retrospective analysis of 1-month treatment outcome on scar severity and patient satisfaction. J Cosmet Dermatol. 2020;19(1):115–121. doi:10.1111/jocd.13004

55. Zhang W, Cheng X, Li H, Cao M. Evaluation of the therapeutic effect of micro-plasma radio frequency on hypertrophic scars in rabbit ears. Lasers Med Sci. 2018;33(9):1961–1968. doi:10.1007/s10103-018-2562-1

56. Song WJ, Nam SM, Park ES, Choi CY, Lee SW. The effectiveness of early combined CO2 ablative fractional laser and 595-nm pulsed dye laser treatment after scar revision. J Craniofac Surg. 2021;32(2):629–631. doi:10.1097/SCS.0000000000006983

57. Chen HY, Lei Y, OuYang HW, Gold MH, Tan J. Experimental comparative study of the effect of fractional CO2 laser combined with pulsed dye laser versus each laser alone on the treatment of hypertrophic scar of rabbit ears. J Cosmet Dermatol. 2022;21(3):979–990. doi:10.1111/jocd.14732

58. Kim S, Cho KH. Clinical trial of dual treatment with an ablative fractional laser and a nonablative laser for the treatment of acne scars in Asian patients. Dermatol Surg. 2009;35(7):1089–1098. doi:10.1111/j.1524-4725.2009.01193.x

59. Kim JC, Kang SY, Kim HO, Park CW, Kwon O, Chung BY. Efficacy of combined treatment with intense pulsed light and fractional erbium:YAGLaser in scar prevention: a randomized split wound trial. Dermatol Ther. 2021;34(5):e15061. doi:10.1111/dth.15061

60. Khedr MM, Mahmoud WH, Sallam FA, Elmelegy N. Comparison of Nd:YAGLaser and combined intense pulsed light and radiofrequency in the treatment of hypertrophic scars: a prospective clinico-histopathological study. Ann Plast Surg. 2020;84(5):518. doi:10.1097/SAP.0000000000002086

61. Li J, Wang D, Wang Y, Du Y, Yu S. Effectiveness and safety of fractional micro-plasma radio-frequency treatment combined with ablative fractional carbon dioxide laser treatment for hypertrophic scar: a retrospective study. Ann Palliat Med. 2021;10(9):9800–9809. doi:10.21037/apm-21-2153

62. Liu XJ, Liu WH, Fang SW, Zhou XL, Xu JX, Li GS. Lasers and intense pulsed light for the treatment of pathological scars: a network meta-analysis. Aesthet Surg J. 2022;42(11):NP675–NP687. doi:10.1093/asj/sjac175

63. Huang J, Zhang S, Ding X, et al. Research progress on the mechanism by which skin macrophage dysfunction mediates chronic inflammatory injury in diabetic skin. Front Endocrinol. 2022;13:960551. doi:10.3389/fendo.2022.960551

64. Tripathi S, Soni K, Agrawal P, Gour V, Mondal R, Soni V. Hypertrophic scars and keloids: a review and current treatment modalities. Biomed Dermatol. 2020;4(1):11. doi:10.1186/s41702-020-00063-8

65. Xu X, Gu S, Huang X, et al. The role of macrophages in the formation of hypertrophic scars and keloids. Burns Trauma. 2020;8:tkaa006. doi:10.1093/burnst/tkaa006

66. Lodyga M, Hinz B. TGF-β1 - A truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 2020;101:123–139. doi:10.1016/j.semcdb.2019.12.010

67. Shirakami E, Yamakawa S, Hayashida K. Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence. Burns Trauma. 2020;8:tkz003. doi:10.1093/burnst/tkz003

68. Saint-Jean M, Khammari A, Jasson F, Nguyen JM, Dréno B. Different cutaneous innate immunity profiles in acne patients with and without atrophic scars. Eur J Dermatol. 2016;26(1):68–74. doi:10.1684/ejd.2015.2713

69. Moon J, Yoon JY, Yang JH, Kwon HH, Min S, Suh DH. Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor-β1 signalling. Br J Dermatol. 2019;181(6):1226–1237. doi:10.1111/bjd.17851

70. Matuszczak E, Tylicka M, Dębek W, Sankiewicz A, Gorodkiewicz E, Hermanowicz A. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) in serum of children after thermal injury. Adv Med Sci. 2017;62(1):83–86. doi:10.1016/j.advms.2016.07.004

71. Ozog DM, Liu A, Chaffins ML, et al. Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser. JAMA Dermatol. 2013;149(1):50–57. doi:10.1001/2013.jamadermatol.668

72. Matuszczak E, Weremijewicz A, Koper-Lenkiewicz OM, et al. Effects of combined Pulsed Dye Laser and Fractional CO2 Laser treatment of burn scars and correlation with plasma levels of collagen type I, MMP-2 and TIMP-1. Burns. 2021;47(6):1342–1351. doi:10.1016/j.burns.2020.12.011

73. Weremijewicz A, Matuszczak E, Sankiewicz A, et al. Matrix metalloproteinase-2 and its correlation with basal membrane components laminin-5 and collagen type IV in paediatric burn patients measured with Surface Plasmon Resonance Imaging (SPRI) biosensors. Burns. 2018;44(4):931–940. doi:10.1016/j.burns.2017.12.001

74. Lin Y, Yamashita M, Zhang J, Ling C, Welham NV. Pulsed dye laser-induced inflammatory response and extracellular matrix turnover in rat vocal folds and vocal fold fibroblasts. Lasers Surg Med. 2009;41(8):585–594. doi:10.1002/lsm.20839

75. Zhang J, Zhou S, Xia Z, et al. 595-nm pulsed dye laser combined with fractional CO2 laser reduces hypertrophic scar through down-regulating TGFβ1 and PCNA. Lasers Med Sci. 2021;36(8):1625–1632. doi:10.1007/s10103-020-03240-7

76. Schmitt L, Amann PM, Marquardt Y, et al. Molecular effects of fractional ablative erbium:YAGlaser treatment with multiple stacked pulses on standardized human three-dimensional organotypic skin models. Lasers Med Sci. 2017;32(4):805–814. doi:10.1007/s10103-017-2175-0

77. Taylor M, Porter R, Gonzalez M. Intense pulsed light may improve inflammatory acne through TNF-α down-regulation. J Cosmet Laser Ther. 2014;16(2):96–103. doi:10.3109/14764172.2013.864198

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.